| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Calcitonin Gene-Related Peptide (CGRP)-Targeted Monoclonal Antibodies and Antagonists in Migraine: Current Evidence and Rationale
|
Cohen, Fred
|
|
|
36 |
3 |
p. 341-358
|
artikel
|
| 2 |
Clinical Features and Drug Retention of TNF Inhibitors in Older Patients with Ankylosing Spondylitis: Results from the KOBIO Registry
|
Kim, Ji-Won
|
|
|
36 |
3 |
p. 411-419
|
artikel
|
| 3 |
Comparative Treatment Persistence with Bone-Targeting Agents Among Asian Patients with Bone Metastases from Solid Tumors: A Multinational Retrospective Cohort Study
|
Shen, Chin-Yao
|
|
|
36 |
3 |
p. 381-392
|
artikel
|
| 4 |
Dengue Vaccines: An Update
|
Torres-Flores, Jesús M.
|
|
|
36 |
3 |
p. 325-336
|
artikel
|
| 5 |
Embracing Change: An International Survey Study on the Beliefs and Attitudes of Pediatric Rheumatologists Towards Biosimilars
|
Demirkan, Fatma Gül
|
|
|
36 |
3 |
p. 421-430
|
artikel
|
| 6 |
HLX11, a Proposed Pertuzumab Biosimilar: Pharmacokinetics, Immunogenicity, and Safety Profiles Compared to Three Reference Biologic Products (US-, EU-, and CN-Approved Pertuzumab) Administered to Healthy Male Subjects
|
Yang, Jingjing
|
|
|
36 |
3 |
p. 393-409
|
artikel
|
| 7 |
Neoadjuvant Immune Checkpoint Inhibitor Therapy in Melanoma: Efficacy, Safety and Timing
|
van Akkooi, Alexander C. J.
|
|
|
36 |
3 |
p. 373-380
|
artikel
|
| 8 |
Novel Migraine Therapies May Reduce Public and Personal Disadvantages for People with Migraine
|
Ambat, Fidel Dominique Festin
|
|
|
36 |
3 |
p. 337-339
|
artikel
|
| 9 |
Passive Immunotherapy Against SARS-CoV-2: From Plasma-Based Therapy to Single Potent Antibodies in the Race to Stay Ahead of the Variants
|
Strohl, William R.
|
|
|
36 |
3 |
p. 231-323
|
artikel
|
| 10 |
Regulatory Evaluation of Biosimilars: Refinement of Principles Based on the Scientific Evidence and Clinical Experience
|
Kurki, Pekka
|
|
|
36 |
3 |
p. 359-371
|
artikel
|
Tijdschrift beschrijving